Tonix presents fibromyalgia drug data at medical congress

March 10, 2026 8:02 AM

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) presented post hoc analyses of Phase 3 data for TONMYA at the 8th International ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found